|
KBTBD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.157500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.76779999999854E-05 |
| Normal-vs-Stage2 |
6.291900E-02 |
| Normal-vs-Stage3 |
1.809440E-01 |
| Normal-vs-Stage4 |
3.202800E-01 |
| Stage1-vs-Stage2 |
5.983000E-01 |
| Stage1-vs-Stage3 |
3.817900E-03 |
| Stage1-vs-Stage4 |
1.682110E-02 |
| Stage2-vs-Stage3 |
2.795800E-01 |
| Stage2-vs-Stage4 |
2.497000E-01 |
| Stage3-vs-Stage4 |
8.279000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.399200E-04 |
| Normal-vs-AfricanAmerican |
1.852180E-01 |
| Normal-vs-Asian |
3.526400E-01 |
| Caucasian-vs-AfricanAmerican |
5.043000E-01 |
| Caucasian-vs-Asian |
8.328400E-01 |
| AfricanAmerican-vs-Asian |
6.768000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.193660E-02 |
| Normal-vs-Female |
9.61969999999646E-05 |
| Male-vs-Female |
4.162400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.392440E-01 |
| Normal-vs-Age(41-60Yrs) |
4.189500E-04 |
| Normal-vs-Age(61-80Yrs) |
6.938100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.912200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.219200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.022000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.584600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.003800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.490980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.599960E-02 |
| Normal-vs-Grade 2 |
9.99279999969183E-07 |
| Normal-vs-Grade 3 |
3.018000E-01 |
| Normal-vs-Grade 4 |
4.156600E-01 |
| Grade 1-vs-Grade 2 |
1.478760E-01 |
| Grade 1-vs-Grade 3 |
2.426300E-02 |
| Grade 1-vs-Grade 4 |
2.708500E-02 |
| Grade 2-vs-Grade 3 |
2.97890000000578E-06 |
| Grade 2-vs-Grade 4 |
3.241500E-03 |
| Grade 3-vs-Grade 4 |
9.402200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.00760000010247E-07 |
| Normal-vs-ccB subtype |
1.645820E-01 |
| ccA subtype-vs-ccB subtype |
2.33759999999084E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.297900E-03 |
| Normal-vs-N1 |
6.663400E-01 |
| N0-vs-N1 |
4.864000E-01 |
|
|
